Finance

Lists
Why is CVRX down 4.07%?
Dive Deeper
CVRX:NASDAQ
CVRx Inc
$2.59
-4.07%
(-0.11) 1D
$2.59
+0.02% (+0.00050)
Pre-market
Closed: Sep 28, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CVRX...
Open
$2.69
High
$2.79
Low
$2.53
Mkt. cap
69.00M
Avg. vol.
715.30K
Volume
10.00
52-wk high
$11.30
52-wk low
$2.20
EPS
-$1.97
Beta
0.76
Shares outstanding
26.64M
No. of employees
223
Open
$2.69
High
$2.79
Low
$2.53
Mkt. cap
69.00M
Avg. vol.
715.30K
Volume
10.00
52-wk high
$11.30
52-wk low
$2.20
EPS
-$1.97
Beta
0.76
Shares outstanding
26.64M
No. of employees
223
News stories
From web sources and news partners
About CVRx Inc
CEO-
Employees223
Founded2000
HeadquartersMinneapolis, Minnesota, United States
SectorMedical device
Websitebarostim.com
Analyst ratings
Based on 6 analysts giving stock ratings to CVRX in the past 3 months
Buy
Buy
3
Hold
3
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for CVRX in the last 3 months.
Highest
Current $2.59
$5.00 (+93.05%)
Average
$4.38 (+69.11%)
Lowest
$3.50 (+35.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Chase Knickerbocker
Craig-Hallum
Hold
Maintained
-
-
09/22/2026
Frank Takkinen
Lake Street
Hold
Reiterated
$3.50
+35.1%
09/22/2026
William Plovanic
Canaccord Genuity
Buy
Maintained
$5.00
+93.1%
09/21/2026
Matthew O'Brien
Piper Sandler
Hold
Reiterated
$4.00
+54.4%
09/22/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
$5.00
+93.1%
08/17/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
08/07/2026
Daniel Brims
Lake Street
Buy
Reiterated
$14.00
+440.5%
05/12/2026
Robbie Marcus
J.P. Morgan
Sell
Reiterated
$6.00
+131.7%
05/12/2026
Thomas Flaten
Lake Street
Buy
Reiterated
$14.00
+440.5%
05/05/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.53 / -$0.52
-2.26%miss
Revenue / Est. (USD)
15.70M / 15.47M
+1.49%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
14.69M
16.02M
14.77M
15.70M
Cost of goods sold
1.94M
2.20M
1.89M
1.98M
Cost of revenue
1.94M
2.20M
1.89M
1.98M
Research and development expenses
3.15M
3.00M
3.08M
3.13M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.88M
22.01M
21.96M
23.62M
Operating expense
25.02M
25.01M
25.04M
26.75M
Total operating expenses
26.96M
27.21M
26.93M
28.73M
Operating income
-12.27M
-11.18M
-12.16M
-13.02M
Other non operating income
875.00K
660.00K
593.00K
560.00K
EBT including unusual items
-12.87M
-11.94M
-13.12M
-14.04M
EBT excluding unusual items
-12.87M
-11.94M
-13.12M
-14.04M
Income tax expense
-3.00K
-7.00K
1.00K
3.00K
Effective tax rate
0.02%
0.06%
-0.01%
-0.02%
Other operating expenses
-
-
-
-
Net income
-12.87M
-11.93M
-13.12M
-14.04M
Net profit margin
-87.61%
-74.48%
-88.83%
-89.42%
Earnings per share
-0.49
-0.46
-0.50
-0.53
Interest and investment income
-
-
-
-
Interest expense
-1.48M
-1.42M
-1.55M
-1.58M
Net interest expenses
-1.48M
-1.42M
-1.55M
-1.58M
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.07M
-11.00M
-11.96M
-12.81M
Gain or loss from assets sale
-
86.00K
1.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps